Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 5,000 shares at $452.45 ($2.3M) on 2015-03-25, disclosed to the SEC on 2015-03-26.
Scheduled sale ($2.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $452.45 | 300 | $136K | 6.0% |
| 2 | $453.71 | 265 | $120K | 5.3% |
| 3 | $454.38 | 1,999 | $908K | 39.9% |
| 4 | $455.48 | 1,536 | $700K | 30.8% |
| 5 | $456.36 | 700 | $319K | 14.0% |
| 6 | $457.21 | 200 |
| $91K |
| 4.0% |
| Total | $454.96 avg | 5,000 | $2.3M | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |
| REGN | SELL | 2013-10-02 | $4.7M | — | Filing → |